Research
Please note that this research may have been paid for by the investment company. Any opinions and ratings are not endorsed by the AIC.
Related articles
Investment trusts: the treatments and takeovers behind the biotech boom
M&A activity drives momentum in biotech and healthcare
Related videos
Me and my trusts: Ian Cowie
Me and my trusts: Ian Cowie - what trusts do you hold and why?
Related industry news
OrbiMed founder Sven Borho steps down with immediate effect
He is leaving the healthcare asset manager he co-founded after 33 years, handing his £1.3bn Worldwide Healthcare Trust over to Trevor Polischuk and Geoff Hsu.
Sven Borho steps down from Worldwide Healthcare Trust
Sven Borho has stepped down as lead portfolio manager of Worldwide Healthcare Trust (LON:WWH) with immediate effect. Borho was a founder of the trust’s New York-based manager OrbiMed Capital.
Sven Borho steps down from Worldwide Health with Biotech Growth’s Hsu becoming co-manager
Worldwide Healthcare Trust (WWH) fund manager Sven Borho has stepped down with immediate effect. The OrbiMed partner, who helps lead the New York firm...
Worldwide Healthcare: Biotech M&A made 89% in 15 months and is “most actively managed” part of our portfolio
Worldwide Healthcare (WWH) made an 89% return from a basket of biotechnology takeover targets in the 15 months to 30 June as mergers and acquisitions ...
Investment company news brought to you by Citywire Financial Publishers Limited,
QuotedData by Marten & Co, Sharesify, and the armchair trader.
Data provided by Morningstar.
Company documents provided by FE fundinfo.